The founders of Phoenix Life Sciences International Limited have committed to The Giving Pledge, investing 50% of their holdings in the Company and their future dividends to fund the Global Health Initiative. The goal of the Global Health Initiative is to provide doctors, patients and consumers around the world with access to medical and research information about medical cannabis. We intend to engage with other cannabis leaders to encourage them to contribute to the Global Health Initiative and be the central resource of medical cannabis education for them and other collaborators.
Our objective is to provide a central, up-to-date and independent source for industry companies to point to for clinical data and research. Phoenix Life hopes to the Global Health Initiative in a variety of projects, including veterans access programs, new healthcare clinics in developing countries, community sports facilities, researching potential treatments for diseases, providing training for putting rehabilitated patients and veterans back into the workforce.
We strive to urge other industry leaders to follow the Giving Pledge and commit 50% of their net worth to positive social causes during their lifetime and be part of these Global Health Initiatives.
For more information, visit our
Global Health Initiative website below:
Transfer Agent Contact:
16540 Pointe Village Dr, Suite 205 Lutz, Florida 33558
Securities Law Disclaimer
The information contained herein has been prepared for informational purposes and is not an offer to buy or sell or a solicitation of an offer to buy or sell any security or to participate in an investment strategy. Any offering of securities shall be pursuant to a definitive Private Placement Memorandum and Subscription Agreement, which may supersede this information in its entirety. This information is intended to be distributed to and viewed only by Accredited Investors as defined by the Securities Act of 1933.
Forward Looking Statements
This presentation contains forecasts of prospective financial information that have been prepared on the basis of assumptions as to future events which management expects to take place and the actions management expects to take as of the date the information is prepared. Past performance may not be indicative of future results. Therefore, no current or prospective investor should assume that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this document, or indirectly via link to any unaffiliated third-party website, will be profitable or equal to corresponding indicated performance levels.
The statements contained herein regarding cannabinoids and treatment options are made based on clinical research of various U.S. approved conditions for cannabis use. These statements have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products have not yet been approved by the FDA to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from healthcare practitioners.